Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 25;31:09636897221139103. doi: 10.1177/09636897221139103

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 3. — Clinical outcomes of haplo-PBSCT with maternal/collateral donors between the ATG-based and low-dose ATG/PTCy-based groups. (A) Probability of overall survival (OS). (B) Probability of relapse-free survival (RFS). (C) Non-relapse mortality (NRM). (D) Cumulative incidences (CIs) of relapse. ATG: antithymocyte globulin; CIR: Cumulative incidence of relapse; HSCT: hematopoietic stem cell transplantation; NRM: non-relapse mortality; PBSCT: peripheral blood stem cell transplantation; PTCy: posttransplant cyclophosphamide; RFS: relapse-free survival.